Jason Zemansky
Stock Analyst at B of A Securities
(4.74)
# 140
Out of 4,711 analysts
33
Total ratings
70.83%
Success rate
26.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $9.01 | +221.86% | 2 | Nov 22, 2024 | |
| INSM Insmed | Maintains: Buy | $84 → $86 | $70.44 | +22.09% | 8 | Oct 9, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $13.08 | +137.00% | 3 | Aug 15, 2024 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $24 → $23 | $15.50 | +48.39% | 4 | Aug 9, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $2.19 | +14.16% | 5 | Jun 20, 2024 | |
| CYTK Cytokinetics | Maintains: Neutral | $70 → $60 | $48.87 | +22.77% | 3 | May 23, 2024 | |
| ALVR AlloVir | Downgrades: Underperform | $17 → $1 | $0.40 | +147.52% | 2 | Dec 26, 2023 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.59 | +528.93% | 4 | May 12, 2023 | |
| ALLK Allakos | Maintains: Buy | $145 → $155 | $1.20 | +12,816.67% | 2 | Dec 13, 2021 |
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $9.01
Upside: +221.86%
Insmed
Oct 9, 2024
Maintains: Buy
Price Target: $84 → $86
Current: $70.44
Upside: +22.09%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $13.08
Upside: +137.00%
Arcus Biosciences
Aug 9, 2024
Maintains: Neutral
Price Target: $24 → $23
Current: $15.50
Upside: +48.39%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $2.19
Upside: +14.16%
Cytokinetics
May 23, 2024
Maintains: Neutral
Price Target: $70 → $60
Current: $48.87
Upside: +22.77%
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17 → $1
Current: $0.40
Upside: +147.52%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.59
Upside: +528.93%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: $145 → $155
Current: $1.20
Upside: +12,816.67%